Alpha Tau Medical Ltd.
DRTS
$4.06
$0.184.64%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | 9.02M | 8.73M | 8.87M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 36.04M | 35.71M | 36.35M | |
| Operating Income | -- | -36.04M | -35.71M | -36.35M | |
| Income Before Tax | -- | -31.74M | -29.63M | -27.65M | |
| Income Tax Expenses | -- | 6.00K | 12.00K | -27.00K | |
| Earnings from Continuing Operations | -- | -31.75 | -29.64 | -27.63 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -31.75M | -29.64M | -27.63M | |
| EBIT | -- | -36.04M | -35.71M | -36.35M | |
| EBITDA | -- | -34.95M | -34.63M | -35.28M | |
| EPS Basic | -- | -0.45 | -0.42 | -0.40 | |
| Normalized Basic EPS | -- | -0.15 | -0.13 | -0.13 | |
| EPS Diluted | -- | -0.45 | -0.42 | -0.40 | |
| Normalized Diluted EPS | -- | -0.15 | -0.13 | -0.13 | |
| Average Basic Shares Outstanding | -- | 279.71M | 279.14M | 278.57M | |
| Average Diluted Shares Outstanding | -- | 279.71M | 279.14M | 278.57M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |